Laboratorium Pathologie Oost Nederland

What Laboratorium Pathologie Oost Nederland does

Laboratorium Pathologie Oost Nederland (LabPON) is a private medical pathology laboratory founded in 1953 and headquartered in Hengelo, Netherlands, with 101-250 employees. It provides diagnostic pathology services — histology, cytology, immunopathology, molecular diagnostics, digital pathology, and post-mortem examination — to regional hospitals across Eastern Netherlands (Oost-Nederland) and to general practitioners nationwide. The laboratory operates within the Dutch NZA tariff system and participates in national population screening programs for cervical cancer (via Roche COBAS 4800 HPV testing) and colorectal cancer (BVO-darmkanker), the latter having achieved excellent audit results for four consecutive years.

LabPON's technology stack centers on validated diagnostic platforms: Roche COBAS 4800 PCR for HPV primary screening, the Omnis Plus immunopathology platform (transitioned in 2025), TSO500 for comprehensive molecular profiling (validated 2025), Milestone Tissue Safe Vacumering for specimen preservation, and digital pathology imaging for remote review. The lab is NEN-EN-ISO 15189:2012 accredited by the RvA (number M268), NEN 7510:2017 certified for healthcare information security, and operates under IVDR for in-house developed IVDs, with the 2025 RvA audit completed with zero deviations. Strategic partnerships include Zivver for secure communications, Bevolkingsonderzoek Nederland for screening programs, and University of Twente and UMC Utrecht for clinical research and pathologist training pipelines.

The business model is B2B service revenue from healthcare providers, billed through nationally regulated NZA tariffs based on weighted diagnostic categories, plus transaction-based fees for archive material requests. Customer segments are organized vertically by healthcare provider type: hospitals (regional anchor clients) and general practitioners (distributed volume). The lab operates without external investors or a parent company under a Supervisory Board governance model, and is currently investing in process automation, digital workflow tools (Regional Diagnostic Portal under development), and capacity expansion through planned in-house pathologist training from January 2027.

Name

Laboratorium Pathologie Oost Nederland

Legal name

Laboratorium Pathologie Oost-Nederland

Website

https://labpon.nl

Company type

Private

Founded year

1953

Operating status

Operating

Headcount range

101–250 employees

Short description

LabPON is a private Dutch medical pathology laboratory in Hengelo providing histology, cytology, immunopathology, molecular diagnostics, digital pathology, and autopsy services to regional hospitals in Eastern Netherlands and general practitioners nationwide, including national cervical and colorectal cancer screening.

Ownership category

akta.pro rank

Product category

Pathology Diagnostic Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

akta.pro secondary industry

Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF)

Keywords

• Pathology diagnostic services
• Histology laboratory
• Cytology diagnostics
• Molecular pathology
• Cancer screening programs

Headquarters

HQ city

Hengelo

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Pathology Diagnostic Services: Pathology examination services billed through a nationally established tariff system using weighted categories based on NZA policy rules. Costs are charged to the patient's health insurer and count toward the deductible.
2. Archive Material Request Fees: Fees for requesting archive materials (reports, blocks, sections) for trials, consultations, and revisions, based on NVVP guidelines

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

LabPON is a medical pathology laboratory performing histological, cytological, immunopathological, molecular, and post-mortem diagnostic examinations of tissue and cell samples submitted by hospitals and general practitioners. It also participates in the Dutch national cervical and colorectal cancer screening programs (BVO) and provides digital pathology, frozen section, and autopsy services. Pricing is set via nationally established NZa tariff categories, billed through patient health insurers.

Differentiator

Problem solved

Functional benefit

Products and services

• Histologie (Histology) Laboratory examination of tissue samples including cutting, embedding, sectioning, and staining for diagnostic purposes, including frozen section (vriescoupe) analysis. Provided for hospital specialists and GPs requiring tissue-based diagnostics.
• Cytologie (Cytology) Laboratory examination of individual cells obtained via smears or punctures, including general cytology and cervical cytology. Provided for hospital specialists and GPs requiring cell-based diagnostics.
• Immunopathologie (Immunopathology) Immunohistochemical diagnostic services using antibody-based detection methods to identify specific antigens in tissue samples, now performed on the Omnis Plus platform. Provided for hospital specialists requiring antigen-specific diagnostic workups.
• Moleculaire diagnostiek (Molecular Diagnostics) Molecular pathology testing including HPV detection (Roche COBAS 4800 PCR test) and the validated TSO500 technique for comprehensive genomic profiling. Provided for hospital specialists and population screening programs requiring DNA/RNA-based diagnostics.
• Digitale pathologie (Digital Pathology) Digital imaging and analysis of pathology specimens enabling remote diagnostics, telepathology, and integration with digital pathology workflows. Provided for hospital specialists and internal diagnostic review.
• Obductie (Autopsy / Post-mortem Examination) Post-mortem examination services including adult, pediatric/neonatal, and skull autopsies, including consultation and reporting on causes of death. Provided for clinicians and families requiring cause-of-death assessment.
• Bevolkingsonderzoek baarmoederhalskanker (Cervical Cancer Screening) Cervical cancer population screening program using HPV testing on the Roche COBAS 4800 platform. Provided to the national cervical cancer screening program (BVO) managed by Bevolkingsonderzoek Nederland.
• Bevolkingsonderzoek darmkanker (Colorectal Cancer Screening) Colorectal cancer population screening program conducted under the national BVO program, with annual accreditation renewal based on successful audit outcomes. Provided to Bevolkingsonderzoek Nederland.
• Aanvraagformulieren (Request/Order Forms) Standardized pathology request forms for cytology, histology, autopsy, urine cytology, cervical smear, and specialized care pathway programs (zorgprogramma's) for colon, prostate, stomach, and esophagus. Provided to hospital specialists and GPs.
• Zorgprogramma's (Care Pathway Programs) Structured diagnostic care pathway programs for colon, prostate, stomach, and esophagus conditions, providing standardized collection instructions and request forms for coordinated diagnostic care. Provided to hospital specialists and GPs.
• Regionaal Diagnostisch Portaal (Regional Diagnostic Portal) Digital portal under development as part of the 'Versneld Verbinden' regional project, designed to optimize the request and access of laboratory diagnostics for primary care providers and strengthen the regional care chain. Under development and not yet commercially available.

Quantifiable outcome

• Zero deviations in RvA audit according to new ISO 15189 guidelines
• +1 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• ZivvercoreTechnology or Integration · 15 February 2019LabPON uses ZIVVER for secure communication of privacy-sensitive information since February 15, 2019. ZIVVER encrypts messages with sensitive content such as patient data and BSN numbers, ensuring only sender and recipient can read the content.
• Bevolkingsonderzoek NederlandcoreStrategic or Co-development PartnerLabPON participates in the colorectal cancer screening program (BVO-darmkanker) conducted by Bevolkingsonderzoek Nederland. The laboratory's accreditation for this screening program is renewed annually based on successful audit outcomes.
• University of TwenteminorStrategic or Co-development PartnerThe science committee strengthens ties with the University of Twente through active participation in clinical studies, supporting research collaboration.
• UMC Utrecht (UMCU)minorStrategic or Co-development PartnerSecond Klinisch Moleculair Bioloog in de Pathologie (KMBP) started training in cooperation with UMCU. Steps taken to offer physician training to become pathologist from January 2027.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Saltro: Dutch diagnostic center providing laboratory diagnostics and imaging services primarily to GPs and primary care. Comparable to LabPON in serving national GP demand and operating routine histology/cytology workflows through ZorgDomein-style channels.
• Labmicta: Regional medical microbiology and pathology laboratory based in the Twente region of the Netherlands. Labmicta is explicitly linked to LabPON operationally — the Bedrijfsbureau (back office) is shared between the two — making it the closest comparable regional pathology/microbiology operator in Eastern Netherlands.
• PAMM (Pathologie en Medische Microbiologie): Dutch pathology and medical microbiology laboratory serving hospitals in the Eindhoven/Central Brabant region. Directly comparable to LabPON as a regional Dutch pathology lab combining histology, cytology and molecular diagnostics for hospital and GP customers.
• Symbiant: Dutch pathology network formed from the merger of several regional labs including Pathologie Friesland. Directly comparable to LabPON as a regional pathology network serving Dutch hospitals with multi-site laboratory operations.
• Stichting Pathologisch Anatomisch Laboratorium (PAL): Regional Dutch pathology laboratory providing diagnostic services to hospitals and GPs. A direct peer to LabPON in terms of service mix (histology, cytology, molecular) and regional-hospital GTM model.

Broad incumbents

• Synlab: Europe's largest medical diagnostics services provider, with extensive operations in Germany and elsewhere in Europe. A broad incumbent in clinical/medical laboratory services whose scale, test menu and digital pathology investments are benchmark competitors to LabPON's regional model.
• Quest Diagnostics: US-listed diagnostics giant offering anatomic pathology, molecular and routine clinical laboratory services globally. Comparable as a broad-incumbent pathology operator with significant investment in digital pathology and AI-assisted diagnostics.
• Cerba Healthcare: European specialty diagnostics provider offering clinical pathology, molecular and genetic testing. Comparable to LabPON as a specialty pathology operator with capabilities in molecular diagnostics and digital workflows.
• Unilabs: Large European medical diagnostics group operating clinical and specialty laboratories across multiple countries. Comparable to LabPON as a clinical/anatomic pathology provider with cross-border scale and a broad molecular diagnostics offering.

Others

• Radboudumc Pathology: Academic pathology department at Radboud UMC in Nijmegen. Not a direct commercial competitor but a relevant Dutch academic comparator for subspecialist pathology reads, training pipelines, and academic-grade molecular diagnostics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/labpon.hengelo
• LinkedInlinkedin.com/company/labpon

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorium Pathologie Oost Nederland